These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23515197)

  • 21. Botulinum neurotoxin type A in facial aesthetics.
    De Boulle KL
    Expert Opin Pharmacother; 2007 Jun; 8(8):1059-72. PubMed ID: 17516871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.
    Jandhyala R
    J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):720-31. PubMed ID: 22225675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aesthetics.
    Poulain B; Trevidic P; Clave M; Aharoni C; Baspeyras M; Bui P; Cartier H; Charavel MH; Coulon P; Dahan S; Dallara JM; Delonca D; Dumas L; Essayagh E; Galatoire O; Georgieu N; Grangier Y; Humbert P; Le Pillouer-Prost A; Mojallal A
    J Drugs Dermatol; 2013 Dec; 12(12):1434-46. PubMed ID: 24301246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global, 3-dimensional approach to natural rejuvenation: part 1 - recommendations for volume restoration and the periocular area.
    Raspaldo H; Gassia V; Niforos FR; Michaud T
    J Cosmet Dermatol; 2012 Dec; 11(4):279-89. PubMed ID: 23174051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multimodal Approach to Rejuvenation of the Lower Face.
    Carruthers J; Carruthers A
    Dermatol Surg; 2016 May; 42 Suppl 2():S89-93. PubMed ID: 27128250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina.
    Banegas RA; Farache F; Rancati A; Chain M; Gallagher CJ; Chapman MA; Caulkins CA
    Aesthet Surg J; 2013 Sep; 33(7):1039-45. PubMed ID: 23990584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New botulinum toxins for aesthetic dermatology : A comprehensive review].
    Patil A; Kassir M; Wollina U; Goldust M
    Hautarzt; 2021 May; 72(5):393-402. PubMed ID: 33822278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IncobotulinumtoxinA for Aesthetic Indications: A Systematic Review of Prospective Comparative Trials.
    Prager W; Nogueira Teixeira D; Leventhal PS
    Dermatol Surg; 2017 Jul; 43(7):959-966. PubMed ID: 28375973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of periorbital rhytids with botulinum toxin type A: maximizing safety and results.
    Spiegel JH
    Arch Facial Plast Surg; 2005; 7(3):198-202. PubMed ID: 15897411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on neurotoxins for facial rejuvenation: what they are, how they work, and how to effectively and safely use them.
    Brennan C
    Plast Surg Nurs; 2015; 35(2):69-75. PubMed ID: 26020471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
    Carruthers J; Fagien S; Matarasso SL;
    Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correcting age-related changes in the face by use of injectable fillers and neurotoxins.
    Rubin MG; Cox SE; Kaminer MS; Solish N
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S81-4. PubMed ID: 25268602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on botulinum neurotoxin use in aesthetic dermatology.
    Ibrahim O; Keller EC; Arndt KA
    Semin Cutan Med Surg; 2014 Dec; 33(4):152-6. PubMed ID: 25830246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the spread of three botulinum toxin type A preparations.
    Kerscher M; Roll S; Becker A; Wigger-Alberti W
    Arch Dermatol Res; 2012 Mar; 304(2):155-61. PubMed ID: 22002325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin in men: review of relevant anatomy and clinical trial data.
    Keaney TC; Alster TS
    Dermatol Surg; 2013 Oct; 39(10):1434-43. PubMed ID: 24090254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pachydermoperiostosis: aesthetic treatment of prematurely aging face with facelift and botulinum toxin a.
    Bingol UA; Cinar C
    J Craniofac Surg; 2014 Nov; 25(6):e563-4. PubMed ID: 25377981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.